Pliant Therapeutics, Inc.(PLRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PLRX Pliant Therapeutics, Inc.

盘前交易 11-05 08:25:08 EST

14.49

-0.03

-0.21%

盘前14.93

+0.44+3.04%

08:01 EST

最高15.25	最低14.18	成交量50.67万
今开14.52	昨收14.52	日振幅7.37%
总市值8.81亿	流通市值6.78亿	总股本6,080万
成交额748.76万	换手率1.08%	流通股本4,682万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PLRX","market":"US","secType":"STK","nameCN":"Pliant Therapeutics, Inc.","latestPrice":14.49,"timestamp":1730754000000,"preClose":14.52,"halted":0,"volume":506655,"hourTrading":{"tag":"盘前","latestPrice":14.93,"preClose":14.49,"latestTime":"08:01 EST","volume":2,"amount":29.86,"timestamp":1730811689094},"delay":0,"floatShares":46815163,"shares":60801425,"eps":-3.087608,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.03,"latestTime":"11-05 08:25:08 EST","open":14.52,"high":15.25,"low":14.18,"amount":7487568.49158,"amplitude":0.073691,"askPrice":16.71,"askSize":100,"bidPrice":12.9,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.087608,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730817000000},"adr":0,"listingDate":1591156800000,"adjPreClose":14.49,"preHourTrading":{"tag":"盘前","latestPrice":14.93,"preClose":14.49,"latestTime":"08:01 EST","volume":2,"amount":29.86,"timestamp":1730811689094},"postHourTrading":{"tag":"盘后","latestPrice":14.49,"preClose":14.49,"latestTime":"16:02 EST","volume":25251,"amount":365886.99,"timestamp":1730754150972},"volumeRatio":1.588858873747349,"impliedVol":0.8638,"impliedVolPercentile":0.6972},"requestUrl":"/m/hq/s/PLRX","defaultTab":"news","newsList":[{"id":"2477893747","title":"Pliant Therapeutics, Inc.盘中异动 急速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477893747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477893747?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:24","pubTimestamp":1729527897,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日00时24分，Pliant Therapeutics, Inc.股票出现波动，股价急速跳水5.00%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Genprex, Inc.、Biovie Inc.、Gri Bio, Inc.涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为7383.13%、3333.00%、1460.16%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、148.15%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102200245798e3d950&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102200245798e3d950&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","PLRX"],"gpt_icon":0},{"id":"2476794029","title":"Pliant Therapeutics, Inc.盘中异动 下午盘快速上涨5.36%报14.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476794029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476794029?lang=zh_cn&edition=full","pubTime":"2024-10-17 01:43","pubTimestamp":1729100597,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日01时43分，Pliant Therapeutics, Inc.股票出现异动，股价大幅拉升5.36%。截至发稿，该股报14.75美元/股，成交量13.0315万股，换手率0.21%，振幅5.46%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101701431798e3cd4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101701431798e3cd4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2474224237","title":"Pliant Therapeutics, Inc.盘中异动 早盘急速拉升5.07%报11.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474224237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474224237?lang=zh_cn&edition=full","pubTime":"2024-10-09 22:41","pubTimestamp":1728484907,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日22时41分，Pliant Therapeutics, Inc.股票出现波动，股价大幅拉升5.07%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Inhibikase Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为673.48%、361.04%、187.66%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Inhibikase Therapeutics, Inc.、Cue Biopharma, Inc.，振幅分别为108.00%、45.37%、39.02%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009224148ab68dfbd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009224148ab68dfbd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2472952014","title":"Pliant Therapeutics, Inc.盘中异动 股价大涨6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472952014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472952014?lang=zh_cn&edition=full","pubTime":"2024-10-04 21:40","pubTimestamp":1728049234,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日21时40分，Pliant Therapeutics, Inc.股票出现波动，股价大幅拉升6.56%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Aditxt, Inc.、Sagimet Biosciences Inc. - Series A、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Aditxt, Inc.、Theriva Biologics, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为5532.65%、26.51%、20.37%，振幅较大的相关个股有Aditxt, Inc.、Sagimet Biosciences Inc. - Series A、Theriva Biologics, Inc.，振幅分别为46.39%、20.02%、11.73%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004214035ab67bc8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004214035ab67bc8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","PLRX"],"gpt_icon":0},{"id":"2461362598","title":"Pliant Therapeutics, Inc.盘中异动 临近收盘股价大涨5.06%报13.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461362598","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461362598?lang=zh_cn&edition=full","pubTime":"2024-08-21 03:41","pubTimestamp":1724182885,"startTime":"0","endTime":"0","summary":"北京时间2024年08月21日03时41分，Pliant Therapeutics, Inc.股票出现波动，股价快速上涨5.06%。截至发稿，该股报13.92美元/股，成交量20.3239万股，换手率0.33%，振幅6.94%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082103412598e3595a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082103412598e3595a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2459479643","title":"Pliant Therapeutics, Inc.盘中异动 大幅拉升5.03%报12.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459479643","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459479643?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:05","pubTimestamp":1723734307,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时05分，Pliant Therapeutics, Inc.股票出现异动，股价快速上涨5.03%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Cingulate Inc.、Tempest Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为6341.27%、2043.73%、571.22%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Tempest Therapeutics, Inc.、Cingulate Inc.，振幅分别为103.98%、79.83%、70.46%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230507ab5ddbc6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230507ab5ddbc6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","PLRX"],"gpt_icon":0},{"id":"2459887981","title":"Pliant Therapeutics, Inc.盘中异动 早盘大幅拉升5.02%报12.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459887981","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459887981?lang=zh_cn&edition=full","pubTime":"2024-08-13 23:01","pubTimestamp":1723561294,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日23时01分，Pliant Therapeutics, Inc.股票出现异动，股价急速拉升5.02%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.77%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃，换手率分别为132.11%、119.42%、27.76%，振幅较大的相关个股有冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029、Tempest Therapeutics, Inc.，振幅分别为58.75%、40.95%、39.71%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813230134ab5d9c4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813230134ab5d9c4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PLRX","BK4139","LENZ"],"gpt_icon":0},{"id":"2458682546","title":"Pliant Therapeutics, Inc.2024财年第二财季实现净利润-55.85百万美元，同比减少35.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458682546","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458682546?lang=zh_cn&edition=full","pubTime":"2024-08-11 00:20","pubTimestamp":1723306804,"startTime":"0","endTime":"0","summary":"8月11日，Pliant Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-55.85百万美元，同比减少35.59%；其中营业收入为0.00美元，每股基本收益为-0.93美元。机构评级：截至2024年8月11日，当前有11家机构对Pliant Therapeutics, Inc.目标价做出预测，其中目标均价为41.36美元，其中最低目标价为32.00美元，最高目标价为47.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811002011958e7566&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240811002011958e7566&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PLRX"],"gpt_icon":0},{"id":"2457840028","title":"Pliant Therapeutics, Inc.盘中异动 大幅拉升11.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457840028","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457840028?lang=zh_cn&edition=full","pubTime":"2024-08-06 21:31","pubTimestamp":1722951072,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日21时31分，Pliant Therapeutics, Inc.股票出现异动，股价急速拉升11.14%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Vbi Vaccines, Inc.、Tenax Therapeutics, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为675.56%、263.15%、200.88%，振幅较大的相关个股有Vbi Vaccines, Inc.、Cingulate Inc.、Seres Therapeutics, Inc.，振幅分别为47.69%、10.37%、10.16%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213113af96333d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806213113af96333d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2457723050","title":"Pliant Therapeutics Inc    预计每股亏损 85 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457723050","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457723050?lang=zh_cn&edition=full","pubTime":"2024-08-05 19:30","pubTimestamp":1722857426,"startTime":"0","endTime":"0","summary":"   * Pliant Therapeutics Inc    将于8月7日公布截至2024年6月30日的季度业绩(估计)，预计该公司的季度收入将有所增长。* LSEG 分析师对 Pliant Therapeutics Inc 的平均预期是每股亏损 85 美分。* 华尔街对 Pliant Therapeutics Inc 的 12 个月目标价中位数为 43.00 美元，高于其上次收盘价 13.87 美元。8月5日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","PLRX"],"gpt_icon":0},{"id":"2452166805","title":"Pliant Therapeutics, Inc.盘中异动 大幅下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452166805","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452166805?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:07","pubTimestamp":1721228849,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时07分，Pliant Therapeutics, Inc.股票出现异动，股价急速跳水5.04%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.56%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。消息层面，截至23时07分，《富国集团维持Pliant Therapeutics买入评级，维持目标价41美元》资讯为影响Pliant Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717230729941f7f0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717230729941f7f0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","PLRX"],"gpt_icon":0},{"id":"2452943685","title":"Needham：重申Pliant Therapeutics(PLRX.US)评级，由买入调整至买入评级, 目标价由38.00美元调整至38.","url":"https://stock-news.laohu8.com/highlight/detail?id=2452943685","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452943685?lang=zh_cn&edition=full","pubTime":"2024-07-17 01:25","pubTimestamp":1721150730,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","BK4139","LENZ","PLRX"],"gpt_icon":0},{"id":"2451262846","title":"Pliant Therapeutics, Inc.盘中异动 早盘股价大涨5.15%报13.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451262846","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451262846?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:46","pubTimestamp":1721051207,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时46分，Pliant Therapeutics, Inc.股票出现异动，股价大幅上涨5.15%。截至发稿，该股报13.41美元/股，成交量6.0658万股，换手率0.10%，振幅4.08%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715214648af926563&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715214648af926563&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2441345051","title":"HC Wainwright &amp; Co.：重申Pliant Therapeutics(PLRX.US)评级，由买入调整至买入评级, 目标价由36.","url":"https://stock-news.laohu8.com/highlight/detail?id=2441345051","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441345051?lang=zh_cn&edition=full","pubTime":"2024-06-07 19:09","pubTimestamp":1717758540,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PLRX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2435351292","title":"BUZZ-Pliant Therapeutics公司肺病药物在中期研究中获得成功，业绩上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2435351292","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435351292?lang=zh_cn&edition=full","pubTime":"2024-05-14 22:46","pubTimestamp":1715697967,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    5月14日 - ** Pliant Therapeutics   股价上涨1.7%至13.90美元** 该公司的实验性特发性肺纤维化(IPF) 药物在中期研究中显示，与患者肺部疾病进展有关的蛋白质减少了 (link) ** 这种名为bexotegrast的药物还能改善咳嗽的严重程度** IPF是肺纤维化中最常见的一种类型，这种疾病会导致肺部结疤** 公司称数据显示瘢痕有可能逆转** 年初至今股价下跌 22.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PLRX","BUZZ","BK4007","LENZ"],"gpt_icon":0},{"id":"2435515073","title":"Pliant Therapeutics, Inc.盘中异动 早盘大幅拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435515073","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435515073?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:31","pubTimestamp":1715693494,"startTime":"0","endTime":"0","summary":"北京时间2024年05月14日21时31分，Pliant Therapeutics, Inc.股票出现波动，股价大幅拉升5.45%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Nutriband Inc C/Wts 、Generation Bio Co.、Taysha Gene Therapies, Inc.涨幅较大，Allarity Therapeutics, Inc.、Transcode Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为35.03%、7.26%、6.50%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Allogene Therapeutics, Inc.、Taysha Gene Therapies, Inc.，振幅分别为21.54%、12.41%、11.67%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142131347a59d86b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405142131347a59d86b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","PLRX"],"gpt_icon":0},{"id":"2434772077","title":"Pliant Therapeutics, Inc.盘中异动 急速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434772077","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434772077?lang=zh_cn&edition=full","pubTime":"2024-05-09 02:26","pubTimestamp":1715192777,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日02时26分，Pliant Therapeutics, Inc.股票出现波动，股价快速下挫5.11%。Pliant Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Pliant Therapeutics, Inc.公司简介：Pliant Therapeutics Inc 是一家临床阶段的生物制药公司，专注于发现和开发治疗纤维化和相关疾病的新疗法。该信息摘要如下：花旗：维持Pliant Therapeutics评级，由买入调整至买入评级, 目标价由45.00美元调整至44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509022617861ebd6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240509022617861ebd6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","PLRX"],"gpt_icon":0},{"id":"2433733217","title":"花旗：维持Pliant Therapeutics(PLRX.US)评级，由买入调整至买入评级, 目标价由45.00美元调整至44.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433733217","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433733217?lang=zh_cn&edition=full","pubTime":"2024-05-08 01:45","pubTimestamp":1715103938,"startTime":"0","endTime":"0","summary":"花旗：维持Pliant Therapeutics(PLRX.US)评级，由买入调整至买入评级, 目标价由45.00美元调整至44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801454187dd3672&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050801454187dd3672&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRX","LENZ"],"gpt_icon":0},{"id":"2433203397","title":"奥本海默：维持Pliant Therapeutics(PLRX.US)评级，由优于大市调整至优于大市评级, 目标价由47.","url":"https://stock-news.laohu8.com/highlight/detail?id=2433203397","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433203397?lang=zh_cn&edition=full","pubTime":"2024-05-07 20:04","pubTimestamp":1715083459,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK4007","PLRX","LENZ"],"gpt_icon":0},{"id":"2433273144","title":"HC Wainwright & Co.：重申Pliant Therapeutics(PLRX.US)评级，由买入调整至买入评级, 目标价36.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433273144","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433273144?lang=zh_cn&edition=full","pubTime":"2024-05-07 18:25","pubTimestamp":1715077528,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Pliant Therapeutics(PLRX.US)评级，由买入调整至买入评级, 目标价36.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405071825328ae4a97c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405071825328ae4a97c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLRX","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://pliantrx.com","stockEarnings":[{"period":"1week","weight":-0.0249},{"period":"1month","weight":0.2567},{"period":"3month","weight":0.1053},{"period":"6month","weight":0.0805},{"period":"1year","weight":-0.1006},{"period":"ytd","weight":-0.1999}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pliant Therapeutics, Inc. 于2015年6月根据特拉华州法律注册成立。该公司是一家临床阶段生物制药公司，致力于发现和开发用于治疗纤维化的新疗法。 他们最初的重点是通过抑制整合素介导的TGF-β活化来治疗纤维化。 该公司利用他们对纤维化生物学的深刻理解，以及他们在药物化学和转化医学方面的专业知识，开发了一套专有工具，旨在快速有效地发现和降低候选产品的风险。 他们的全资主要候选药物PLN-74809是整合素的口服小分子双重选择性抑制剂，该公司正在开发该药物用于治疗特发性肺纤维化或IPF，原发性硬化性胆管炎或PSC。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.188578},{"month":2,"riseRate":0.25,"avgChangeRate":-0.023967},{"month":3,"riseRate":0.25,"avgChangeRate":-0.064037},{"month":4,"riseRate":0.25,"avgChangeRate":-0.114241},{"month":5,"riseRate":0.25,"avgChangeRate":-0.087511},{"month":6,"riseRate":0.25,"avgChangeRate":0.028855},{"month":7,"riseRate":0.4,"avgChangeRate":0.179086},{"month":8,"riseRate":0.4,"avgChangeRate":-0.00646},{"month":9,"riseRate":0.4,"avgChangeRate":-0.043943},{"month":10,"riseRate":0.4,"avgChangeRate":0.037983},{"month":11,"riseRate":0.4,"avgChangeRate":-0.024247},{"month":12,"riseRate":0.5,"avgChangeRate":0.033282}],"exchange":"NASDAQ","name":"Pliant Therapeutics, Inc.","nameEN":"Pliant Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pliant Therapeutics, Inc.(PLRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Pliant Therapeutics, Inc.(PLRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Pliant Therapeutics, Inc.,PLRX,Pliant Therapeutics, Inc.股票,Pliant Therapeutics, Inc.股票老虎,Pliant Therapeutics, Inc.股票老虎国际,Pliant Therapeutics, Inc.行情,Pliant Therapeutics, Inc.股票行情,Pliant Therapeutics, Inc.股价,Pliant Therapeutics, Inc.股市,Pliant Therapeutics, Inc.股票价格,Pliant Therapeutics, Inc.股票交易,Pliant Therapeutics, Inc.股票购买,Pliant Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pliant Therapeutics, Inc.(PLRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Pliant Therapeutics, Inc.(PLRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}